Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:1053-1058
Published online before print April 7, 2005, doi: 10.1161/01.STR.0000163080.82766.eb
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/5/1053    most recent
01.STR.0000163080.82766.ebv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lacombe, P.
Right arrow Articles by Joutel, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lacombe, P.
Right arrow Articles by Joutel, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETAZOLAMIDE
Related Collections
Right arrow Animal models of human disease
Right arrow Brain Circulation and Metabolism

(Stroke. 2005;36:1053.)
© 2005 American Heart Association, Inc.


Original Contributions

Impaired Cerebral Vasoreactivity in a Transgenic Mouse Model of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Arteriopathy

Pierre Lacombe, PhD; Charleen Oligo; Valérie Domenga; Elisabeth Tournier-Lasserve, MD Anne Joutel, MD, PhD

From the Génétique des Maladies Vasculaires, INSERM U740, Faculté de Médecine Lariboisière-Saint Louis, Paris, France.

Correspondence to Pierre Lacombe, Génétique des Maladies Vasculaires, INSERM U740, Faculté de Médecine Lariboisière-Saint Louis, 10, Avenue de Verdun, 75010 Paris, France. E-mail lacombe{at}ext.jussieu.fr

Background and Purpose— Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited small vessel disease causing stroke and dementia. The disease is caused by highly stereotyped mutations in NOTCH3, which is restrictively expressed in vascular smooth muscle cells (VSMCs). The mechanisms of compromised cerebral hemodynamics in CADASIL remain to be elucidated. We tested the hypothesis that mutant NOTCH3 impairs the vasomotor function of cerebral vessels.

Methods— Vasomotor function was examined in vivo in transgenic mice expressing a mutant NOTCH3 in VSMCs (TgNotch3R90C). Mice develop an age-dependent arteriopathy similar to that seen in CADASIL, without brain parenchyma lesions. Using laser-Doppler flowmetry, we assessed in awake TgNotch3R90C mice and wild-type littermates the cerebrovascular reactivity to 2 potent vasodilator stimuli (acetazolamide and hypercapnia) and cerebral blood flow (CBF) autoregulation during stepwise blood pressure elevations and reductions. Mice were studied at 18 months of age, when the CADASIL features are apparent, and at 10 months of age, before their appearance.

Results— Eighteen-month-old TgNotch3R90C mice showed reduced responses to hypercapnia and acetazolamide, higher cerebrovascular resistance during hypertension, and their lower limit of CBF autoregulation was shifted to higher blood pressures. Cerebrovascular responses were similarly impaired in 10-month-old TgNotch3R90C mice.

Conclusions— Cerebrovascular reactivity is compromised early in TgNotch3R90C mice. The data show an impaired autoregulation and are suggestive of a decreased relaxation or increased resistance of cerebral vessels. Our findings indicate that vascular dysfunction is an early pathogenic event that may promote the subsequent development of brain ischemia in CADASIL.


Key Words: autoregulation • CADASIL • laser-Doppler flowmetry




This article has been cited by other articles:


Home page
FASEB J.Home page
G.-R. Dou, Y.-C. Wang, X.-B. Hu, L.-H. Hou, C.-M. Wang, J.-F. Xu, Y.-S. Wang, Y.-M. Liang, L.-B. Yao, A.-G. Yang, et al.
RBP-J, the transcription factor downstream of Notch receptors, is essential for the maintenance of vascular homeostasis in adult mice
FASEB J, May 1, 2008; 22(5): 1606 - 1617.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
H. S. Markus
Genes, endothelial function and cerebral small vessel disease in man
Exp Physiol, January 1, 2008; 93(1): 121 - 127.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. A. Moskowitz and T. Kurth
Blood Vessels, Migraine, and Stroke
Stroke, December 1, 2007; 38(12): 3117 - 3118.
[Full Text] [PDF]


Home page
BrainHome page
H. K. Shin, P. B. Jones, M. Garcia-Alloza, L. Borrelli, S. M. Greenberg, B. J. Bacskai, M. P. Frosch, B. T. Hyman, M. A. Moskowitz, and C. Ayata
Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy
Brain, September 1, 2007; 130(9): 2310 - 2319.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
T. Gridley
Notch signaling in vascular development and physiology
Development, August 1, 2007; 134(15): 2709 - 2718.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Blondeau, O. Petrault, S. Manta, V. Giordanengo, P. Gounon, R. Bordet, M. Lazdunski, and C. Heurteaux
Polyunsaturated Fatty Acids Are Cerebral Vasodilators via the TREK-1 Potassium Channel
Circ. Res., July 20, 2007; 101(2): 176 - 184.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Viswanathan, J.-P. Guichard, A. Gschwendtner, F. Buffon, R. Cumurcuic, C. Boutron, E. Vicaut, M. Holtmannspotter, C. Pachai, M.-G. Bousser, et al.
Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study
Brain, September 1, 2006; 129(9): 2375 - 2383.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Q. Miao, T. Paloneva, S. Tuisku, S. Roine, M. Poyhonen, M. Viitanen, and H. Kalimo
Arterioles of the Lenticular Nucleus in CADASIL
Stroke, September 1, 2006; 37(9): 2242 - 2247.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
V. Hachinski, C. Iadecola, R. C. Petersen, M. M. Breteler, D. L. Nyenhuis, S. E. Black, W. J. Powers, C. DeCarli, J. G. Merino, R. N. Kalaria, et al.
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards
Stroke, September 1, 2006; 37(9): 2220 - 2241.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Kidoguchi, M. Tamaki, T. Mizobe, J. Koyama, T. Kondoh, E. Kohmura, T. Sakurai, K. Yokono, and K. Umetani
In Vivo X-Ray Angiography in the Mouse Brain Using Synchrotron Radiation
Stroke, July 1, 2006; 37(7): 1856 - 1861.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Cumurciuc, P. Henry, C. Gobron, E. Vicaut, M.-G. Bousser, H. Chabriat, and K. Vahedi
Electrocardiogram in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Patients Without Any Clinical Evidence of Coronary Artery Disease: A Case-Control Study
Stroke, April 1, 2006; 37(4): 1100 - 1102.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. S. Markus and M. J. Alberts
Update on Genetics of Stroke and Cerebrovascular Disease 2005
Stroke, February 1, 2006; 37(2): 288 - 290.
[Full Text] [PDF]


Home page
StrokeHome page
H. Chui and I. Skoog
Advances in Vascular Cognitive Impairment 2005
Stroke, February 1, 2006; 37(2): 323 - 325.
[Full Text] [PDF]